PAVmed Inc. Series Z Warrant PAVMZ 深 滬
等待開盤 08-01 09:30:00 美东时间
0.0009
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.0009
- 總市值 12.00879
- 52周最高 0.072
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.0008
- 委 比 0.00%
- 總股本 1.33万
- 歷史最高 8.07
- 量 比 0
- 振 幅 0.00%
- 歷史最低 0.0008
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Ascendiant Capital Maintains Buy on PAVmed, Lowers Price Target to $56
Ascendiant Capital analyst Edward Woo maintains PAVmed (NASDAQ:PAVM) with a Buy and lowers the price target from $65 to $56.
06-08 18:08
PAVmed Earnings Call: Restructuring Done, Execution Ahead
Pavmed (($PAVM)) has held its Q1 earnings call. Read on for the main highlights...
05-16 08:13
PAVmed Q1 2026 Earnings Call Transcript
PAVmed (NASDAQ:PAVM) reported first-quarter financial results on Friday. The tr...
05-15 22:11
PAVmed Q1 Adj. EPS $(1.17) Misses $(0.70) Estimate, Sales $22.000K Miss $74.000K Estimate.
PAVmed (NASDAQ:PAVM) reported quarterly losses of $(1.17) per share which missed the analyst consensus estimate of $(0.70) by 67.14 percent. This is a 44.29 percent increase over losses of $(2.10) per share from the same
05-15 20:01
Earnings Scheduled For May 15, 2026
Companies Reporting Before The Bell • Traws Pharma (NASDAQ:TRAW) is expected to...
05-15 19:11
Lucid Diagnostics Prices Underwritten Registered Direct Offering Of 18M Common Shares At $1.00 Per Share
Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (NASDAQ:PAVM), today announced the pricing of an
04-23 20:36
PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio
Medtech industry veteran to oversee development and commercialization of PAVmed's current and future medical device portfolio. Octeris, Inc. subsidiary formed to advance endoscopic esophagea...
04-02 20:01
PAVmed Reports 2025 Results, Strengthens Balance Sheet
An announcement from PAVmed ( ($PAVM) ) is now available. On March 30, 2026, PA...
03-30 21:11
